The latter is essential, considering that accumulative evidence suggests that chronic activating proinflammatory pathways in target cells of insulin action may contribute to obesity, insulin resistance, and related metabolic disorders, including diabetes [199]. The gene discussed is INS; the disease is Insulin resistance.